Pre-market hot trades in US stocks: CAMP4 Therapeutics up 8.43% in pre-market; Recon Tech up 8.33% in pre-market
I'm LongbridgeAI, I can summarize articles.CAMP4 Therapeutics pre-market up 8.43%; Recon Tech pre-market up 8.33%; Kala Pharmaceuticals pre-market up 64.34%; Domo-B pre-market up 41.47%; NextPlat pre-market up 33.49%
Popular Pre-Market Trades in US Stocks
CAMP4 Therapeutics is up 8.43% in pre-market trading. There are no significant recent news; trading is active with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no_news
Recon Tech is up 8.33% in pre-market trading, with no significant recent news. Trading is active with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Top Gainers in Pre-Market US Stocks
Kala Pharmaceuticals is up 64.34% in pre-market trading. Based on recent key news:
-
On March 11, Kala Bio announced the launch of its Researgency.ai platform and plans to release its first commercial AI product in about 14 days. The platform targets the AI healthcare market, projected to exceed $180 billion by 2030, driving a significant increase in stock price. Source: GlobeNewswire
-
On March 11, Kala Bio plans to rebrand the Researgency.ai platform and launch the first AI agent specifically designed for biotechnology. This innovative development demonstrates the company's technological leadership in the biotechnology industry, further boosting market confidence. Source: GlobeNewswire
-
On March 11, Kala Bio cited Gartner data showing a 1445% increase in enterprise inquiries for multi-agent AI systems from Q1 2024 to Q2 2025. This data indicates a surge in market demand for AI technology, supporting the rise in stock price. Source: GlobeNewswire The AI healthcare market is growing rapidly, with broad industry prospects.
Domo-B is up 41.47% in pre-market trading. Based on recent key news:
-
On March 10, Domo announced its fourth-quarter earnings report, exceeding market expectations. The company reported earnings per share of $0.03, far surpassing the expected -$0.17, driving a significant increase in stock price. Source: Benzinga
-
On March 11, Domo's subscription revenue grew by 2% year-over-year, and billings increased by 8%, indicating strong customer demand and market confidence. Source: Business Wire
-
On March 11, analysts rated Domo as "Buy," predicting a 12-month price target of $11.50, indicating significant upside potential from the current price. Source: Reuters The data analysis industry has performed strongly recently, with AI applications driving growth.
NextPlat is up 33.49% in pre-market trading. Based on recent key news:
- On March 11, NextPlat's Global Telesat Communications division secured a two-year contract worth up to $820,000. The order involves providing satellite-supported IoT terminals and related hardware for NATO military end-users This news has driven a significant increase in NextPlat's stock price.
On March 11, NextPlat announced its terminal uses Iridium's Certus satellite network, which includes dual-mode satellite and LTE connectivity. This technological advantage further enhanced market confidence in NextPlat, promoting the rise in stock price. The increasing demand for satellite communication has driven the stock price up